CLVS

Clovis Oncology, Inc.

Delisted

CLVS was delisted on the 20th of December, 2022.

153 hedge funds and large institutions have $220M invested in Clovis Oncology, Inc. in 2020 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 39 increasing their positions, 42 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$61.7M
Puts
$29.6M
Net Calls
Net Calls Change

Top Buyers

1 +$6.2M
2 +$6.14M
3 +$3.81M
4
CAC
Cowen and Company
New York
+$2.96M
5
IC
Ikarian Capital
Texas
+$2.62M

Top Sellers

1 -$35.9M
2 -$3.27M
3 -$2.67M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$2.49M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.48M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$29.5M
2
$28.3M
3
$24.1M
4
$23.3M
5
$10.2M
6
$8.53M
7
$6.36M
8
$6.36M
9
$5.82M
10
$5.35M
11
$4.74M
12
$4.41M
13
$3.81M
14
$3.75M
15
$3.69M
16
$2.96M
17
$2.62M
18
$2.6M
19
$2.39M
20
$2.21M
21
$2.18M
22
$2.12M
23
$1.98M
24
$1.85M
25
$1.8M